Citation

Inoue T, Takemura M, Fushimi N, Fujimori Y, Onozato T, Kurooka T, Asari T, Takeda H, Kobayashi M, Nishibe H, Isaji M.: Mizagliflozin, a novel selective SGLT1 inhibitor, exhibits potential in the amelioration of chronic constipation. Eur J Pharmacol, Volume 806, 2017

Authors

Asari T, Fujimori Y, Fushimi N, Inoue T, Isaji M., Kobayashi M, Kurooka T, Nishibe H, Onozato T, Takeda H, Takemura M

Journal

Eur J Pharmacol

Year

2017

DOI

10.1016/j.ejphar.2017.04.010

PubMed

28410751

Machine-readable

REST APIRDF